Conversa Health


Allscripts Invests in Conversa’s Clinically Intelligent Conversation Platform

Jul '17

The global health IT organization will offer the startup’s solution to its customers

Conversa CEO West Shell III spoke with HEALTH TRANSFORMER about his company’s new partnership with Allscripts.

Digital health startup Conversa announced today that Allscripts, one of the world’s largest providers of health IT products and services, has partnered with it and joined its $9 million Series A. As part of its agreement with the startup, Allscripts will add Conversa’s clinically intelligent conversation platform to its population health management solution, CareInMotion.

“We’ll be integrating with their care management solutions, and be able to automate digital conversations as part of their care plan process,” explained West Shell III, CEO and cofounder of Conversa, a StartUp Health company. “We are in essence a patient-facing touchpoint for their solutions.”

Consisting of a suite of care management technologies, CareInMotion is currently in use at over 950 hospitals around the U.S. According to Allscripts, the provider-facing solution manages 12 million hospitalizations annually, or 27% of the country’s acute and post-acute care referrals. In its partnership with Conversa, Allscripts will supply existing customers with the startup’s conversation platform, and offer it to its customer base of 2,500 hospitals and health systems.

“Our strategic partnership with Conversa will help our clients have more meaningful, personalized, and ongoing interactions with their patients,” said Allscripts CEO Paul Black. “We are proud to introduce our clients to a like-minded innovator that is making a significant impact in the market.”

Conversa allows patients to engage in personalized conversations with their health data.

As a participant in Conversa’s Series A, Allscripts joins an impressive list of digital health investors, including HealthGrades, Epic Ventures, Triple Tree, and Northwell Health, the largest health system in New York. According to Shell, the members of this prestigious group see the value of Conversa’s platform, which builds patient profiles from a range of data sources, and then uses its library of conversation modules to engage in personalized communication with each patient, delivering digital check-ups and updating care teams on the patient’s status.

“Being able to efficiently deliver personalized communication to a patient—and to collect, analyze, and manage patient-generated data—gives care teams a huge advantage,” said Shell. “It allows them to have a much broader group of patients within their population that they can monitor and manage more efficiently.”

So far, 2017 has been a year of tremendous growth for Conversa. In the past seven months, the startup has partnered with Healthgrades, closed a $9 million Series A, and expanded its leadership team and board of directors. In the Allscripts partnership, Conversa has gained what Shell refers to as “a deep distribution partner” that will allow it to scale significantly.

“Having a world-class partner adopt our platform, integrate it with their solutions, and offer it to their customer base gives us much greater scale,” said Shell. “It really accelerates the growth of our company, allowing us to continue focusing on enhancing and improving our platform.”

Learn more about Conversa’s partnership with Allscripts


In case you missed it